Objective: To identify currently available generic and disease-specific health-related quality of life (HRQOL) instruments for children and adolescents up to 19 years old, to describe their content, and to review their psychometric properties. Study Design: Previous reviews on the subject and a new literature review from 2001 to December 2006 (MEDLINE, the ISI Science Citation Index, HealthSTAR and PsycLit) were used to identify measures of HRQOL for children and adolescents. The characteristics (country of origin, age range, type of respondent, number of dimensions and items, name of the dimensions and condition) and psychometric properties (reliability, validity, and sensitivity to change) of the instruments were assessed following international guidelines published by the Scientific Committee of the Medical Outcomes Trust. Results: In total, 30 generic and 64 disease-specific instruments were identified, 51 of which were published between 2001 and 2005. Many generic measures cover a core set of basic concepts related to physical, mental and social health, although the number and name of dimensions varies substantially. The lower age limit for self-reported instruments was 5-6 years old. Generic measures developed recently focused on both child self-report and parent-proxy report, although 26% of the disease-specific questionnaires were exclusively addressed to proxy-respondents. Most questionnaires had tested internal consistency (67%) and to a lesser extent test-retest stability (44.7%). Most questionnaires reported construct validity, but few instruments analyzed criterion validity (n = 5), structural validity (n = 15) or sensitivity to change (n = 14).
Introduction
There is a growing interest in assessing health-related quality of life (HRQOL) in children and adolescents, not only within the research setting, but also in clinical practice [1] . As a consequence, a considerable number of instruments to measure HRQOL in children and adolescents have now been developed. HRQOL has been defined as referring to "the physical, psychological, and social domains of health, seen as distinct areas that are influenced by a person's experiences, beliefs, expectations, and perceptions" [2] . It is therefore usually considered to be a multidimensional construct and its evaluation generally relies on the patient's subjective evaluation of well-being and/or functioning within the different domains comprising the overall construct. Measuring HRQOL is nowadays an important outcomes indicator in evaluating health-care interventions and treatments, in understanding the burden of disease, in identifying health inequalities, in allocating health resources, and in epidemiological studies and health surveys. In clinical practice, it has been suggested that HRQOL instruments can be useful in identifying and prioritizing health problems for individual patients, facilitating communication between patients and health-care staff, identifying hidden or unexpected health problems, as aids to decisionmaking, and in monitoring changes in patients' health state or in detecting responses to treatment [3] .
Instruments developed to measure HRQOL include both generic and disease-specific measures. The former are used to collect information on healthy as well as ill children, at the population level or in clinical practice, and allow for the comparison of HRQOL across different conditions and settings and between healthy and ill children. Disease-specific instruments, on the other hand, aim to collect information on symptoms or disease-specific health problems from more specific populations with a given disease or symptom (e.g., pain or aspects of treatment) [1] . Disease-specific instruments tend to be more sensitive to treatmentrelated changes [4] .
A literature search identified several reviews of instruments to measure HRQOL in children and adolescents. The most wide-ranging of these reviews focused on the conceptual framework [5] [6] [7] , the use of HRQOL instruments in clinical trials [8, 9] , and on identifying and evaluating all available published instruments [10] [11] [12] . The most complete of these reviews [11] identified 18 generic instruments and 24 disease-specific measures. Rapid developments in the HRQOL field, and the increasing number of measures available, underline the need for a new review. These reviews also highlighted some limitations of the then available instruments as well as important changes in the field [7, [10] [11] [12] . These included: confusion regarding the definition of quality of life (QOL), heterogeneity in the number and content of dimensions [13] ; limited availability of disease-specific instruments; discrepancies between child and parent ratings; limited availability of measures for self completion by children; the cultural appropriateness of measures for use in a different context from the original; the advantages and disadvantages of profile and index measures and the measurement of preference values (utilities) in pediatric populations.
Advances in health care and health technology together with rapid developments in the field of patient-reported outcomes (PRO) measurements, imply the need to update and refine these systematic reviews of HRQOL instruments and their psychometric characteristics to help researchers choose the best instrument for their needs. The aim of this study was to identify currently available generic and diseasespecific HRQOL instruments for children and adolescents up to 19 years old, to describe their content, and to assess their psychometric properties.
Methods

Search Strategy
To identify all available instruments, two search strategies were used. First, we analyzed three previous reviews (those by Rajmil et al. [10] , Eiser et al. [11] , and Harding et al. [12] ) to identify all HRQOL instruments for children or adolescents developed or published between 1980 and 2000.
To identify HRQOL instruments developed and/or published between 2001 and December 2006, we carried out an original search of databases using combinations of keywords such as "child" [MeSH] OR "adolescent" [MeSH] OR adolescent* OR child* OR teenage* [ti] OR kid* [ti] OR pediatr* OR pediatr* AND "questionnaires" [mh] NOT adult [mh] OR "health surveys" OR "quality of life" [majr] OR "quality of life" [ti] OR "health status" [majr] OR "health status" [ti] OR "functional status" [ti] OR "well being" [ti] OR "perceived health status." Databases searched included MEDLINE, the ISI Science Citation Index, HealthSTAR and PsycLit. We also hand-searched references from eligible articles, congress abstract books, and the gray literature, as well as contacting experts working in the field and consulting virtual libraries of PRO instruments (ProQolid and Bibliopro) [14, 15] . Searches were restricted to English, French and Spanish language documents.
Inclusion and Exclusion Criteria
Documents included for further analysis were those reporting the development, psychometric assessment and/or use of instruments measuring QOL, health status or well being and intended specifically for children and adolescents up to the age of 19 years. Instruments could be completed by the children or adolescents themselves or proxies (parents, caregivers, or health workers), or both.
Documents reporting on the use of instruments in pediatric samples were excluded from the analysis if the measures used were originally designed for use in adults or the general population. Articles or other documents reporting the use of functional scales and symptom checklists, the results of clinical applications or population studies using HRQOL instruments, and articles reporting on the cultural adaptation of instruments were also excluded from further analysis.
Instruments were included if they were subjective measures intended to collect data on QOL, health status, well-being, and/or functioning.
Procedure
Documents identified by the systematic search were checked for relevance by three reviewers (M.D.E., V.S.S., M.S.) and data from documents considered eligible for inclusion was extracted using a standardized form. Any discrepancies regarding the relevance of the article for the review were resolved through consensus or in consultation with a fourth reviewer (L.R.).
The following characteristics of instruments identified by the review were recorded: country of origin, age range, type of respondent (child/adolescent self-report, parent/proxy, both), number of dimensions and items, name of the dimensions, psychometric properties (reliability, validity, and sensitivity to change), and condition, in the case of disease-specific questionnaires.
Analysis
Generic and disease-specific instruments are presented separately in the results. When determining the number of instruments, different versions of the same instrument (e.g., versions for different age groups, short versions, etc.) were counted as one. Dimensions in these instruments were analyzed to determine the extent to which content varied between generic instruments.
For each instrument included in the review, the psychometric properties of reliability, validity, and sensitivity to change were evaluated in accordance with recommendations in the scientific literature on the desirable characteristics of HRQOL instruments [16, 17] .
Reliability refers to the extent to which the instrument is free from random error, and is usually assessed by measuring the scale's internal consistency and testretest reliability [18] . Internal consistency refers to the fact that all items are homogeneous and measure the same construct, and test-retest reliability refers to the reproducibility or stability over time of domain and overall scores when the conditions of measurement do not change. Minimal standards for reliability coefficients are usually set at 0.70 for use at group level and 0.90-0.95 for use at individual level [18] [19] [20] . Reliability analysis was categorized as follows: (0) not reported; (-) reliability is not acceptable in terms of either internal consistency and/or test-retest (<0.70 in 40% or more of the dimensions); (+) only one type of reliability (internal consistency or test-retest) has been tested, with acceptable results; (++) both internal consistency and test-retest stability are acceptable (>0.70 in 70% or more dimensions).
Validity is the extent to which an instrument measures what it intends to measure [21] . Validity usually includes the measurement of structural validity, construct validity, and criterion validity. Structural validity refers to the extent to which the instrument's structure, as determined by confirmatory factor analysis, reflects a priori expectations of a theoretical-conceptual model based on clinical and biopsychosocial paradigms [16] , and some authors consider it to be part of construct validity [22] . Construct validity measures the extent to which the questionnaire confirms a priori hypotheses, including its capacity to detect expected differences between groups of subjects (known groups validity) or associations with other instruments measuring constructs which are expected to be correlated (convergent validity) [16] . Criterion validity refers to the degree to which scores on the instrument being validated correlate with scores on an external marker, which can be accepted as a "gold standard" [16] . For example, criterion validity for a dimension measuring academic achievement might be tested by examining the relationship between scores on the dimension and the results provided in school reports. Validity is assessed by determining the degree to which hypothesized relations are observed in practice. Validity was classified as: (0) not reported; (-) validity is not acceptable in one or more aspects (structural, construct and/or criterion); (+) one type of validity tested, with acceptable results; (++) two types of validity tested with acceptable results; (+++) all three types of validity tested with acceptable results.
Sensitivity to change refers to the ability of the questionnaire to detect clinically important changes in health status or HRQOL over time [16] . Although there are different statistics to assess sensitivity to change, such as the standardized response mean and measurement error, in the great majority of the articles reviewed the effect size was used. We therefore based our evaluation of a questionnaire's sensitivity to change on this measure, and considered a minimum effect size of 0.2 as acceptable. Sensitivity to change was assessed as: (0) not reported; (-sec) assessed, but with negative results or (+s) assessed with acceptable results.
Results
From previous literature reviews, we identified a total of 43 generic and disease-specific PRO instruments published before 2001, which met the study inclusion criteria. Two generic instruments were excluded because they were originally developed for use in adults (the Sickness Impact Profile and the Quality of Well-Being Scale) and one disease-specific instrument was excluded because it was considered to be a checklist (Play Performance Scale for Children).
The search of publications between 2001 and 2006 revealed 1041 documents, which were potentially eligible for further analysis based on their titles and abstracts. Of these, 870 did not meet the inclusion criteria: 336 because they reported on clinical applications and population studies of pediatric questionnaires, 317 because they were not studies of HRQOL instruments, 111 because they referred to instruments designed for use in adult subjects, 100 because they referred to QOL studies but not to instrument development or validation (qualitative studies, comparisons between instruments, adaptations), and 6 because they were letters or editorials. A total of 171 documents were reviewed and 51 HRQOL instruments developed and/or published since 2001 were identified.
Combining the results of the two phases of the review produced a total of 94 instruments addressed to pediatric populations. Of these, 30 were generic instruments and 64 were disease-specific. Several of the instruments (specifically, 13 generic and 14 diseasespecific instruments) included versions for different age groups (toddler, child, adolescent) and/or short-form versions of the original instrument. Table 1 shows the characteristics of the generic instruments identified and Table 2 those of the diseasespecific instruments, together with results for the nine key attributes reviewed.
Generic Instruments
Of the 30 generic HRQOL instruments identified, nine were published between 2001 and 2006. In regard to the questionnaires existing in 2001, four new versions have been developed for different age groups [23] [24] [25] [26] .
Country of origin. Generic instruments were predominantly developed in the United States (n = 10) and UK (n = 7). Only one instrument was developed simultaneously in more than one country [27, 28] , leading to a version for each country involved.
Age range. The majority of instruments were developed for children aged 5 years or over. Only two generic instruments targeted early childhood (0-5 years) [29, 30] . New versions published since 2001 focused particularly on early childhood [23] [24] [25] .
Respondent. Thirteen instruments use exclusively child or adolescent self-report [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] ; four use only proxy reports [29, 30, 50, 51] ; and 13 measures included both children/adolescent self-report and proxy responses [23] [24] [25] 27, 28, [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] . One instrument also collected information from nurses [29] .
Dimensions/items. The number of dimensions ranged between 3 [36] and 17 [38] . The number of items ranged from 6 [34, 35] to 183 [56, 57] . Seven questionnaires provide only an overall score and no score by dimension; the majority provide both an overall score and a score by dimension [31] [32] [33] 39, 46, 50, 51, 72] . Based on the names of the dimensions (Table 3) , the most commonly measured concepts were self-esteem, body image and autonomy (n = 13), physical activity (n = 12), emotional status (n = 11), and school and leisure (n = 11).
Other characteristics. Illustrative figures (smiley faces, cartoons, etc.) were included as visual aids in five of the generic instruments [23, 34, 35, 38, 54, 58, 59, 61] . Optional disease-specific modules were available for four generic instruments [31, 53, 61, 67, 68] .
Psychometric properties. Among generic instruments, only 16.7% reported both internal consistency and test-retest data [24, [42] [43] [44] [45] [46] [56] [57] [58] [59] 62] ; 40% of the instruments only provided data on internal consistency [23, 25, 27, 28, 31, 36, 47, 49, 50, 52, 53, 61, [67] [68] [69] [70] 72] ; and 20% only on test-retest reliability [29, 34, 35, 37, 38, 48, 60, 63, 64] . In all of these cases, the reliability coefficients met accepted standards. In 13% of cases [30, 40, 41, 55, 71] , reliability did not meet accepted standards, and two instruments did not provide data on either type of reliability [51, 65, 66] .
The majority of the questionnaires reported acceptable construct validity (83.3%); one instrument did not fulfill the previously established criteria for construct validity [55] , and no data on this type of validity were provided for three instruments [39, 46, 47, 49, 72] . Criterion validity was assessed in only four instruments, with acceptable results in all cases [30, 42, 43, 50, [56] [57] [58] [59] . Structural validity using factor analysis was examined in 23.3% instruments, with satisfactory results in terms of the fit statistics used [31, [42] [43] [44] [45] 52, [56] [57] [58] [59] 62, [67] [68] [69] [70] . Only 10% of instruments reported data on sensitivity to change, all with acceptable results [27, 28, 53, 62, 67, 68] .
Disease-specific instruments.
A total of 64 diseasespecific HRQOL instruments were identified; 65.6% were published since 2001. Of the questionnaires existing in 2001, a new version for a different age group was developed for one questionnaire [73] , and there were new short versions for two questionnaires [74] [75] [76] .
Conditions included. Asthma (n = 10), cancer (n = 8), and epilepsy (n = 7) were the most frequent conditions identified in the list of 27 conditions covered by the disease-specific instruments. From 2001 on, new questionnaires were developed for a total of 18 conditions.
Country of origin.
Disease-specific instruments were predominantly developed in the United States (n = 22), UK (n = 10) and Canada (n = 10). Five of the instruments developed since 2001 were developed simultaneously in more than one country [77] [78] [79] [80] [81] [82] [83] [84] [85] .
Age range. Most of the instruments identified were developed for use in populations aged 5 years or over, although some could be used in populations less than 5 years (32.8%). Instruments targeting broader age ranges usually had different versions for different age groups (e.g., 5-12 and 13-18), and some use a combination of self-reports for older respondents and proxy reports for younger subjects [86] [87] [88] . Instruments developed since 2001 tended to include younger age groups, with ages as low as 1 and 2 years.
Respondents. Of the disease-specific instruments identified, 43 .7% relied exclusively on child self-reports [73, 73, 76, 85, , 26.6% only on parent reports [105, 112, [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] and 29.6% on both child and proxy reports [74, 75, 77, 79, 83, 86, 87, [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] . One instrument also included a nurse-reported version [132] . Of the instruments developed since 2001, 12 were exclusively parent/proxy reports, 14 were exclusively self-report instruments, and 14 used a combination of the two.
Dimensions/items. The number of dimensions ranged from 2 [94, 105] to 12 [83] and the number of items ranged from 5 [114, 127] to 178 [131] . Six instruments only provided an overall score but no score by dimension [92, 106, 110, 123, 124, 129, 130] . The most common concepts addressed in the instruments were emotional well-being (n = 30), friends/social functioning (n = 28), physical function (n = 23), symptoms, (n = 14) and treatment (n = 11).
Other characteristics. Illustrative figures were used in two instruments [94, 107] .
Psychometric properties. In terms of reliability, data solely on internal consistency were provided for 28% of the disease-specific instruments [73,73,77,78,85,89, 90, 92, 97, 103 -105, 112, 116, 118,131-134,140,141] , 4.7% provided data solely on test-retest reliability [90, 109, 124] , and 45.3% provided data on both types of reliability [79, 80, 82, [86] [87] [88] 91, [93] [94] [95] [96] 99, 102, [106] [107] [108] 113, 114, 118, 121, 122, 125, 126, 128, 129, 135, 136, [138] [139] [140] 142] . Results met accepted standards in almost all cases. In two cases [98, 127] , reliability did not meet accepted criteria, and this property was not assessed for 18.75% instruments [83,99-101, 110,111,115,120,121,123,130,137,145] . The majority of the questionnaires reported on some aspect of construct validity (71.9%). Only one instrument tested criterion validity, with acceptable The results of the present review suggest that HRQOL measures for children and adolescents are generally multidimensional instruments designed to measure the respondent's subjective point of view regarding the impact of disease and treatment on physical, psychological, and social functioning. In that sense, the instruments identified reflect theoretical considerations regarding the HRQOL concept [9] . The wide range in content and differences in the number of dimensions and items are likely to reflect differences in the development process, the theoretical framework applied, the target population, and/or the instrument's intended use.
The number of disease-specific instruments has grown exponentially in recent years, with the same number of instruments being produced in the last 5 years as in the previous 20 years. Disease-specific instruments now exist for 27 conditions. Although many of the disease-specific instruments developed since 2001 have relied substantially on child/ adolescent self-report, the review also suggests that there is still a substantial reliance on parent/proxy reports. Fifteen of the new instruments developed since 2001 were exclusively parent report instruments, despite the fact that studies have shown discrepancies between child and parent ratings [11] . The majority of these new instruments were likewise not intended for use in very young children or infants, where it may be justifiable to only use parent/proxy ratings [117] . Scale developers ought to consider producing child selfreports versions of new instruments, whenever it is feasible to collect such reports. Children should also be involved at critical stages in the instrument development process, through focus groups, individual interviews, and in the phases of item reduction and validation.
Obtaining self-reports of HRQOL from younger children (children aged below 8) was one of the challenges mentioned by Eiser and Morse, and although the need for a minimal level of cognitive capacity represents a limitation, some instruments [58, 59] , with the help of illustrations and interview administration, have reduced the minimum age for self-report to as low as 5-6 years [59] . Different formats have also been tested in younger children, although there is no consensus yet about which is the most appropriate [105, 116, 121, 127, 128, 131, 146] . Techniques such as item response theory [147, 148] , item banking, and computer adaptive testing might also provide promising avenues of research by reducing the number of items needed to measure HRQOL while maintaining acceptable levels of precision and reliability [149] . Another advantage of IRT is that it permits the identification of items which function differently across groups (e.g., groups defined by sex, age, or culture). Examples of age-appropriate computer-assisted instruments are the CAT-screen [150] and the Animated Computer Program [151] , although their psychometric properties have not been tested [152] .
Another recent development has been the simultaneous production of a small number of instruments in different countries [27, 28, [77] [78] [79] [80] 83, 85] , using experience gained in the development of the World Health Organization Quality of Life (WHOQOL) measure [153] . This approach facilitates their use and comparability in international studies, as well as helping to ensure content validity across different language versions. At the same time, although it requires considerable resources at the beginning of the process, it also avoids a number of the pitfalls and limitations involved in the cultural adaptation of existing measures.
In terms of psychometric properties, the majority of the instruments included meet accepted standards of internal consistency and validity, although relatively few provide data on test-retest reliability, structural validity, and sensitivity to change. The lack of evidence on sensitivity to change is of particular concern for clinical trials, longitudinal studies or when monitoring patients over time. Developers should aim to assess this characteristic during instrument testing, for example, by comparing scores on the instrument before and after an intervention of known efficacy. For use at the population level, developers also need to consider means of testing whether their instruments are suitable for exploring health inequalities between different population subgroups, such as those defined by socioeconomic status, sex, or immigrant status. Finally, for use in clinical practice [154, 155] aspects such as brevity, ease of administration and scoring, and interpretability need to be taken into account. It is also worth noting that we based the present review on "standard" conceptions of reliability and validity, whereas new theoretical models proposed in the literature question existing methods for assessing reliability and validity, and set out new approaches for describing the scales' psychometric properties [156, 157] . These could be taken into account in future reviews.
As well as identifying some of the methodological shortcomings of existing instruments, the current review has also indicated areas where disease-specific HRQOL instruments are lacking. For example, there are no such instruments for use in overweight and obese children, children with eating disorders, or with mental disorders such as depression. To date research on the use of utility measures in pediatric populations has been limited, although at least three preferencebased instruments for children and adolescents have been developed [26, 37, 38, 63, 64, 115] . Other researchers have examined correlations between child-specific measures and the EQ-5D preference-based measure [158] . Nevertheless, a recent review highlighted some of the problems of HRQOL measurement for costutility studies in pediatric populations [159] .
When selecting an HRQOL instrument, it is important to consider whether the questionnaire suits the purpose of the investigation, if the dimensions covered are relevant to the context, and the availability of the questionnaire for the age group of interest. The type of respondent should be taken into account, and users should choose instruments with demonstrated reliability and validity, as well as ensuring that the instrument has demonstrated sensitivity to change if the aim is to evaluate the effectiveness of an intervention, or monitor the evolution of health status over time. In clinical practice, a useful strategy may be to incorporate both generic and disease-specific questionnaires, or to use one of the existing questionnaires that integrate both generic and disease-specific modules. It should also be borne in mind that the date of development of measures will affect the amount of psychometric validation that has taken place and/or which is available in the published literature.
Limitations of the present study include the fact that instruments published to 2001 were identified from earlier reviews, which exposes the present study to any weaknesses inherent in those studies, such as the use of a limited number of databases for the search, and restrictions on languages in which the searches were performed [10] [11] [12] . Nevertheless, the quality and coverage of the earlier reviews was considered to be high and by combining three reviews we aimed to minimize the risk of inadvertently omitting relevant instruments. Inclusion criteria in the second phase of our review were also not the same as those in the previous reviews. Despite using stricter inclusion criteria, however, we still identified a large number of new questionnaires.
In conclusion, the production of HRQOL instruments for children and adolescents has continued apace in recent years, particularly as regards diseasespecific questionnaires. There is still substantial heterogeneity among both generic and disease-specific instruments in terms of content and length. More research is required into the test-retest reliability, structural validity, and sensitivity to change of HRQOL instruments for children and adolescents.
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